NBlaz – Lifestyle
Author:
Daniel J. Edelman Inc. dba Edelman on behalf of itself and its Affiliates
Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease
May 7, 2026
Johnson & Johnson study shows TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn’s disease
May 7, 2026
Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend
May 1, 2026
When the Stakes Are High, So Is the Sweat: Dove Men+Care Targets Wedding-Day Pressure
May 1, 2026
DOVE ADVANCES HAIRCARE INNOVATION WITH NEW UV REPAIR & GLOW COLLECTION, DESIGNED TO REPAIR AND PROTECT HAIR FROM UV DAMAGE
April 30, 2026
Wellspect HealthCare Expands Surity™ Portfolio in the U.S. with Surity™ Male External Catheter for Urinary Incontinence Care
April 30, 2026
NEW PURE LEAF MENTAL FOCUS ICED TEA: INTRODUCING THE BRAND’S FIRST FUNCTIONAL ICED TEA LINE WITH OLYMPIC GOLD MEDALIST JORDAN CHILES
April 28, 2026
FDA grants Priority Review for IMAAVY® (nipocalimab-aahu) as the potential first approved treatment for people living with warm autoimmune hemolytic anemia (wAIHA)
April 27, 2026
White Claw® and Teddy Swims Partner to Bring Friends Together Year-Round
April 23, 2026
Spencer Stuart Appoints Bill Launder as Chief Communications Officer
April 21, 2026
1
2
3
4
Next Page
→